Apogee Therapeutics, Inc. Common Stock
APGE
$134.85+0.04%
Delayed · as of Aug 25, 2026, 9:57 AM ET
Mkt cap
$2.34B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-2.20
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Use this APGE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full APGE income, balance, and cash tables.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company in the Healthcare sector.
Latest cached Apogee Therapeutics, Inc. Common Stock (APGE) net income for FY2025 was -$255.8M. Statements: https://lician.com/financials/apge
Apogee Therapeutics, Inc. Common Stock (APGE) market capitalization is $2.34B on the latest cached snapshot.
Apogee Therapeutics, Inc. Common Stock (APGE) cached previous close $134.79; day range $134.81 – $134.86; volume 40,197. Session quote: https://lician.com/quote/apge
Apogee Therapeutics, Inc. Common Stock (APGE) latest cached earnings event is "APGE earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached APGE filing is 8-K · Sep 3, 2026. Filings: https://lician.com/sec/apge